Back
Bristol Myers Squibb Co. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Buy
68
BMY
Bristol Myers Squibb Co.
Last Price:
$55.91
Seasonality Move:
0.1%
Buy
65
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$44.87
Seasonality Move:
97.02%
Buy
68
Bristol Myers Squibb Co. (BMY)
is a Buy
Is Bristol Myers Squibb Co. a Buy, Sell or Hold?
-
The current Bristol Myers Squibb Co. [BMY] share price is $55.90. The Score for BMY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $41.42. The Score for RGC is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol Myers Squibb Co.'s stock price today?
-
The Bristol Myers Squibb Co. share price today is $55.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $41.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.41 | Buy |
| Relative Strength Index (14 RSI): | 65.77 | Buy |
| Chaikin Money Flow: | -10217329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.91 - 54.97) | Buy |
| Bollinger Bands (100): | (44.32 - 51.54) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.89 | Buy |
| Relative Strength Index (14 RSI): | 67.99 | Buy |
| Chaikin Money Flow: | -1949190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.46 - 30.82) | Buy |
| Bollinger Bands (100): | (10.82 - 22.22) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.48 | Buy |
| 20-day SMA: | 53.93 | Buy |
| 50-day SMA: | 50.19 | Buy |
| 200-day SMA: | 48.42 | Buy |
| 8-day EMA: | 54.82 | Buy |
| 20-day EMA: | 53.65 | Buy |
| 50-day EMA: | 51.11 | Buy |
| 200-day EMA: | 49.44 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.29 | Buy |
| 20-day SMA: | 23.74 | Buy |
| 50-day SMA: | 17.76 | Buy |
| 200-day SMA: | 14.47 | Buy |
| 8-day EMA: | 33.46 | Buy |
| 20-day EMA: | 26.08 | Buy |
| 50-day EMA: | 20.45 | Buy |
| 200-day EMA: | 14.25 | Buy |
Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.16 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bristol Myers Squibb Co. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||